Oncostatin M for Anti-HBV Therapy: Can a Foe Be Turned Into a Friend?

被引：1
|
作者：
Cheng, Tao
Cheng, Yun
Jin, Dong-Yan [1 ]
机构：
[1] Univ Hong Kong, Sch Biomed Sci, Pokfulam, Hong Kong, Peoples R China
来源：
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY | 2024年 / 17卷 / 02期
关键词：
HEPATITIS-B-VIRUS; INTERFERON;
D O I：
10.1016/j.jcmgh.2023.11.005
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：309 / 310
页数：2
相关论文
共 50 条
  • [31] Anti-tumor Necrosis Factor Therapy for Crohn Disease: Friend or Foe to the Surgeon?
    Kim, Hungdai
    ANNALS OF COLOPROCTOLOGY, 2015, 31 (04) : 121 - 122
  • [32] In vitro susceptibility of HBV polymerase encoding mutations acquired during adefovir dipivoxil therapy to other anti-HBV agents
    Qi, Xiaoping
    Xiong, Shelly
    Yang, Huiling
    Miller, Michael D.
    Delaney, William
    HEPATOLOGY, 2006, 44 (04) : 252A - 253A
  • [33] Efficacy and effectiveness of anti-HBV therapy with early withdrawal of HBIG prophylaxis to prevent HBV recurrence following liver transplantation
    Ku, Winston
    Wang, Uerica
    Nguyen, Mindie H.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (05) : 665 - 677
  • [34] A Mathematical Model of the Dynamics for Anti-HBV Infection Therapy with Chinese Herbs plus Adefovir Dipivoxi
    Min, Lequan
    Ye, Yongan
    2009 3RD INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING, VOLS 1-11, 2009, : 3000 - +
  • [35] Dynamical behaviour of an anti-HBV infection therapy model with time-delayed immune response
    Zhuo, Xinjian
    Su, Yongmei
    2013 7TH INTERNATIONAL CONFERENCE ON SYSTEMS BIOLOGY (ISB), 2013, : 86 - 91
  • [36] A mathematical model for anti-HBV infection combination therapy with Peginterferon Alfa-2a and Lamivudine
    Zhang, Guo
    Zhao, Hong
    Xie, Qizhi
    2010 4TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING (ICBBE 2010), 2010,
  • [37] Anti-TNF Therapy During the SARS-CoV-2 Pandemic: Friend or Foe?
    Levartovsky, Asaf
    Ben-Horin, Shomron
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (04): : 517 - 518
  • [38] CHARACTERIZATION OF HBV GENOTYPE EPIDEMIOLOGY AND HBSAG TITRES IN RESPONSE TO ANTI-HBV ANTIVIRAL THERAPY IN CANADIAN TERTIARY REFERRAL LIVER CENTRES
    Congly, Stephen E.
    Wong, Philip
    Al-Busafi, Said A.
    Fung, Scott K.
    Ghali, Peter
    Betel, Michael
    Fonseca, Kevin
    Myers, Robert P.
    Osiowy, Carla
    Coffin, Carla S.
    HEPATOLOGY, 2011, 54 : 893A - 893A
  • [39] Effectiveness of prophylactic anti-HBV therapy in allogeneic hematopoietic stem cell transplantation with HBsAg positive donors
    Hui, CK
    Lie, A
    Au, WY
    Ma, SY
    Leung, YH
    Zhang, HY
    Sun, J
    Cheung, WWW
    Chim, CS
    Kwong, YI
    Liang, R
    Lau, GKK
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (06) : 1437 - 1445
  • [40] Inhibition of nonhomologous end joining-mediated DNA repair enhances anti-HBV CRISPR therapy
    Murai, Kazuhiro
    Kodama, Takahiro
    Hikita, Hayato
    Shimoda, Akiyoshi
    Fukuoka, Makoto
    Fukutomi, Keisuke
    Shigeno, Satoshi
    Shiode, Yuto
    Motooka, Daisuke
    Higuchi, Yuichiro
    Miyakawa, Kei
    Suemizu, Hiroshi
    Ryo, Akihide
    Tahata, Yuki
    Makino, Yuki
    Yamada, Ryoko
    Sakamori, Ryotaro
    Tatsumi, Tomohide
    Takehara, Tetsuo
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (09) : 2474 - 2487
12345